Usage: LEXISCAN® (regadenoson) injection is indicated as a pharmacologic stress agent for radionuclide myocardial perfusion imaging (MPI) in patients who cannot perform adequate exercise stress.
Usage: Regadenoson injection is indicated as a pharmacologic stress agent for radionuclide myocardial perfusion imaging (MPI) in patients who cannot perform adequate exercise stress testing.
Usage: Regadenoson injection is indicated as a pharmacologic stress agent for radionuclide myocardial perfusion imaging (MPI) in patients who cannot perform adequate exercise stress tests.
Usage: Regadenoson injection is indicated as a pharmacologic stress agent for radionuclide myocardial perfusion imaging (MPI) in patients who are unable to perform adequate exercise stress testing.
Usage: Regadenoson injection is indicated as a pharmacologic stress agent for radionuclide myocardial perfusion imaging (MPI) in patients who cannot perform adequate exercise stress testing.
Usage: Regadenoson injection is indicated as a pharmacologic stress agent for radionuclide myocardial perfusion imaging (MPI) in patients who are unable to perform adequate exercise stress.
Usage: Regadenoson Injection is indicated as a pharmacologic stress agent for radionuclide myocardial perfusion imaging (MPI) in patients who cannot perform adequate exercise stress.
Usage: Regadenoson injection is indicated as a pharmacologic stress agent for radionuclide myocardial perfusion imaging (MPI) in patients who are unable to perform adequate exercise stress testing.
Usage: Regadenoson injection is indicated as a pharmacologic stress agent for radionuclide myocardial perfusion imaging (MPI) in patients who cannot perform adequate exercise stress testing.
Usage: Regadenoson Injection is indicated as a pharmacologic stress agent for radionuclide myocardial perfusion imaging (MPI) in patients who cannot perform adequate exercise stress testing.